ARCHIVES

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

DCE Recompetition Of Human Tissue Procurement Approved

November 23, 1990

MRI Predicts If Chemo Working In Preoperative Therapy

February 25, 2005

As Avastin Decision Nears, Patient Groups Split On PFS In Front Line Breast Cancer.

February 22, 2008

President Obama Signs FDA User Fee Act Into Law

July 13, 2012

Oral Contraceptives Related To Liver Tumors; New Studies Urged

March 12, 1976

In Brief: Carbone To Leave NCI for Wisconsin ACS’ Holleb Says Tobacco Industry Tries to Hide Ad Warning

October 3, 1975